Matthias Liechti
Professor of Clinical Pharmacology
Key Impact
World-leading clinical researcher focusing on the human pharmacology of MDMA, LSD, and other psychoactive substances at the University of Basel.
Background & Research
Matthias Liechti is a Swiss scientist and physician, currently serving as a Professor of Clinical Pharmacology and Internal Medicine at the University of Basel. He heads the Liechti Lab at the University Hospital Basel, which is globally recognized for its rigorous clinical trials on the acute effects of LSD, MDMA, and psilocybin. His research interests span psychopharmacology, pharmacokinetics, and the development of novel treatments for psychiatric disorders.
Collaboration Network
51 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Healthy VolunteersAnxiety DisordersMedicinal Chemistry & Drug DevelopmentDepressive DisordersNeuroimaging & Brain MeasuresInterpersonal Functioning & Social ConnectednessPersonality & Trait FactorsPTSDPalliative & End-of-Life DistressMicrodosingSafety & Risk ManagementChronic PainSubstance Use Disorders (SUD)Headache Disorders (Cluster & Migraine)SchizophreniaAdolescentsSet & SettingMajor Depressive Disorder (MDD)Neurocognitive DisordersOlder AdultsImmunology & InflammationPublic Health, Prevention & Behaviour ChangeSuicidalityObsessive-Compulsive Disorder (OCD)Bipolar DisorderTobacco/Nicotine Use Disorder (TUD)Treatment-Resistant Depression (TRD)Personality Disorders